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Twenty Ni-reactive T -lymphocyte clones were ob-
tained from eight different donors and a nalyzed for 
their ability to cross-react with other metals. All 
Ni-reactive T-lymphocyte clones were CD4+CD8 -
and recogniz ed Ni in association with either HLA-DR 
or -DQ molecules. B ase d on the periodic table of the 
e l ements , the metals Cr, Fe, Co, Cu, and Zn from the 
same horizontal row as Ni, and Pd and Pt from the 
sam e vertical r ow, were selected to study T -lympho-
cyte clone cross-r eactivity. Distinct cross-reactivity 
patterns were found that could be divided into three 
m ajor groups: Ni-reactive T-lymphocyte clones i) 
c ross-reacting with Cu, ii) cross-reacting with Pd, or 
iii) without cross-reactivity. Major histocompatibility 
A Uergic con tact dermatitis (ACD) develo ps as a de-layed- type hype rsensitivity reactio n tri ggered by re-peated contact of the skin v.rith con tact alle1·gens. T he reaction is m edi ated by allergen-specifi c T lym phocytes, accumul ating in the skin [1]. T he m ost 
commo n compo und to ca use ACD in m an is nickel (Ni) , with up to 
10% skin tes t positivity in the Ca ucasian po pulatio n [2] . Lower 
frequ encies of m etal-i nduced ACD have been reported fo r C u, Co, 
Fe, Pd , and C r [2]. R ecently, Ni- reactive T cells were fo und to 
recognize the m etal when associated to amino acid res idu es of 
pep tides in the pocke ts o f majo r histocompatibili ty compl ex 
(MHC) class Il m o lecul es, o r directly to the MHC class II 
molecul es [3,4] . 
In 11i11o patch test results in humans have show n that ACD to 
di ffe rent m eta ls can occur simul taneously [2] . It is uncl ear whether 
ACD to vari o us m eta ls o rigin ates fro m cross-reactivi ty of m etal-
reactive T lym phocytes or fro m concomitant sensitiza tion . A nalys is 
of m urine M H C class Il-restricted T -lymphocyte clones (TLC) 
reactive to the hapten 2,4,6-trinitrophenyl (T N P) has shown a high 
specific ity of this in te raction , in tha t these clones could not be 
activa ted by closely related haptens [5]. O n the o ther hand, murin e 
T N P-specific cytotoxic TLC, w hich recognize T NP in associati on 
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complex class 11-restriction patterns of Cu- and Pd-
induced proliferative responses did not differ from 
those for the Ni-induced responses . Iu vitm cross-
reactivities with Cu and Pd may be favored by their 
bivalency and location next to Ni in the periodic 
table, and the similarity of these metals to Ni in 
binding to histidine residues ofpeptides in the pocket 
of major histocompatibility complex class II mole-
cules . The present findings suggest that Cu and Pd 
hypersensitivities, which are occasionally observed in 
Ni-allergic patients, may be due to cross-reactivities 
at the T -cell clonal level rather than to concomitant 
sensitization. Key wovds: alle1:gic contact devmatitis!T cells/ 
metalslpvolifevation. J Iuves t D evmatol 105:92-95, 1995 
w ith albumin-derived peptides, can crossreact with the related 
hapten 2,4-dinitrophenyl [6]. 
In the presen t stud y we have investigated the abili ty o f Ni-
reacti ve TLC to cross-react with o ther m etals by m easur ing the i11 
11itro pro lifera tive respon ses of these T LC to vario us m e tals. For this 
study, human Ni-reactive TLC were prepared from vario us Ni-
aJi ergic donors (7,8]. All TLC were C D 3 +CD4+C D8 - , and rec-
ognized Ni i11 an HLA-DR o r HLA-D Q dependen t fas hio n [7,8] . 
Based o n M endeleev's periodic table o f the elem ents the fo llo wing 
physically and chemically related m etals w e re selec ted fo r cross-
reactivity studies: Cr, Fe, Co , Cu, and Zn fro m the sam e group 
(horizontal row) as Ni, as well as Pd and Pt fro m the sam e period 
(vertical row) as Ni. Co, C u, Z n, Pd and Pt were tested as bivalent 
m eta l-ions. In additio n C r and Fe, tested as trivalent cations, were 
included beca use they resemble the Ni-ca tion in size. 
M ATEIU ALS AN D METH ODS 
Patients Ni- reactive TLC 2/36, 3/4, 3/35, and 3/36 (a k ind gift of Dr. 
F. Sinigaglia, R oche Milano Ricerche, Milano, Ita ly) were derived from 
two patients ob tai ned at the Canton H ospital of Basel, Switzerl and [7]. 
Other N i- reactive TLC were derived from six patients obtained at d1e 
Academ ic Medica l Center, University of Am sterdam [8]. T he pati en ts had 
been pa tch-tes ted with the general European standard skin test batte ry of 
con tact all ergens , evaluated by the recommendations of the Inte rnational 
Con tact Dermatitis R esearch Group (ICDR G). T his battery incl udes the 
m etal s N i and Co, bu t not C u and Pd . Posi ti ve skin patch tests to Ni were 
fo und in all patients. Pos itive skin patch test to Co was fo und in patien t 8. 
Culture Me dium and Cell Culturing T cells were either cultured in 
IU>M I 1640 (Gibco Labo ratori es, Paisly, Scotland) supplemented wid1 
L-gluta mine (2 mM), l % nonessen tia l amino acids, 1% sodium pyntvate, 50 
U / ml penicillin, 50 J.Lg/ml streptomycin, 5 X 1 o-s M 2-mercap toeth:mol 
and 10'X• pooled A.B serum o r l O'X, feta l bovine serum , or in IM D M (Gibco 
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F igure 1. Crossreactivity of Ni-reactive T lymphocyte clones 3/36 
and MDS.2 with other metals . T LC cells (2- 4 X 104 we ll) were cu ltured 
w ith au tologous APC (irradiated PBMC, :1 05 / well) in the presence o r 
ab sen ce o f va rio us conccn tnltions o f m etal salts. After 48 h the cultures w ere 
p ubed with 1 p.Ci of 3 1-l-TdR, and proliferati on was m easured after 16 h . 
T he data arc expressed as mean :t SO . T he m etals Z n , Pt, C r, H g, and Fe 
induced n o signi ficant pro li fe ra tive respo nses (data no t shown). 
Laborato ri es) , supp le m en ted with gentam ycin (80 p.g/m l; D uchefa, H aar-
lem , T h e N etherl ands) and l O'X1 pooled , heat-inacti vated human serum 
(HS ; Central Labo ratory Blood T ransfu sio n Serv ice, Amsterdam, T he 
N e the rlands) o r 10% fe ta l bovine se rum (1-lyclo ne , Logan , UT ) . All cul tures 
were incubated at 37"C in a humidifi ed atm osphere containing 5% C02 . 
Metal s The m e tals used w e re NiS0.1 · 61-1 20, C uS0.1 · 51-1 20, PdC I2 , 
Fe2 [S04 ], . CoCI2 , Z n C 12 , PtCI2 , and C rC 13 • 61-1 2 0 (all from Sigm a, St. 
Louis, MO). Purest availab le fo rms of m etal salts w ere employed implying 
that the m e tal sal ts contained less than 0.05% of con taminating m e tals [9]. 
Stock solution s w ere prepared fo r all m etals at a con centration of20 mM in 
d o uble-di stilled water. T he io n concentratio n in do uble-distill ed water was 
below 10 - 8 M . Stock solu ti ons w ere 0.2 p.m fi lter sterilized and dil u ted 
w ith cu lture m edi a to the desired fina l concentrations, from 0.:1 to 300 p.M. 
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Cloning o f Ni-speci fic T cells Peripheral blood m ononuclear cell s 
(PBM C) ofN i-a ll erg ic patie nts w ere isolated from heparinized w hole blood 
b y density cen tri fugation on Ficoll-Hypaq ue (Pharm acia Fine C hemicals 
All, Up psa la, Sweden). TLC were prepared as described ea rl.ier: for dono rs 
1 and 2 we u sed cloning procedure A [7], fo r dono rs 3- 8 we used clon ing 
procedure 13 (8]: 
C /ouiug procedure A : PBMC (4 X 1 06) were cul tured in 24-wcll Costar 
pla tes in 2 m l R PM I supplem ented w ith 10% l-IS in the presen ce of 5 X 
·1 o-s M NiS0.1. After 6 d . lym phoblasts were enri ched on a discontinuo us 
Percoll gradient, cul tured w ith recombinan t interleukin-2 (IL-2, 10 U / m l, 
1-lolfm an-La R.oche , Nutley. NJ) fo r 2 weeks, and subsequently restimu-
la ted w ith Ni in th e presence of autologous, irradi ated (2500 rad) PBMC fo r 
5 d. T he resulti ng cell su spensions were transferred in to in terl cukin 2 (lL- 2) 
(10 U/m l) containing m edium and , afte r ano tl1er 7 d , clon ed by limiting 
diluti on . Cells were seeded at 0 .3 cells/well in Terasaki trays in tl1e presence 
of phyto hem agglutinin (PH A) (2 p.g/ml) and 1 0'1 a llogeneic irradiated 
PBM C and IL-2. Afte r 2 w eeks , growtl1 of cells was detected m icroscopi-
ca lly and growing cells were expanded further in m edium supplem ented 
w ith PH A. allogeneic irrad iated PBM C. and IL- 2 . 
Clouiug procedure B: PBMC (2 X 1 0 5) were cul tured in 96-well Costar 
p lates in the presence of l X 10 - 4 M or 5 X 10 - 5 M NiS02 • After 7 d 
N i- reactivc T cell lines were expanded in IL- 2 (3 U / ml ; Cetus, Emeryville, 
CA) containing m edi um fo r another 7 d. T he cell s were then cloned b y 
limiting dilu tion by cul tu6ng 0 .3 ce lls/well in th e presence of 2 X 10
5 
irradiated (3000 rad) allogeneic PBMC, 2 X 10'1 irradiated (3000 rad) 
a llogeneic Epstein-Barr virus (EllV)- tran sfo rmcd B cells. PHA (1 p.g/ml. 
Difco , Detro it, Ml), and 10 U / m l IL - 2. Afte r 2 weeks, grow th of cells was 
detected microscopicall y and grow ing cell s were transferred an d restimu-
lated wi th 2 X 106 irradiated (3000 rad) allogeneic PBM C, 2 X 105 
irrad iated (3000 rad) a llogene ic £BY-transformed J3 cells, PI-lA (1 p.g/ml) 
and IL-2 (1 0 U / ml) every o th er 2 weeks in 24-we ll plates. 
Prolifer ation Assay s 2- 4 X 104 TLC were cultured in 0.2 m l RPM! or 
IM O M supplem en ted wi th l 0% l-I S in fl at-botto m ed 96- wcll plates w ith 
either 1 X 105 irradia ted auto logous PBMC or J X l 04 irradiated autologous 
EBV-B cell s in the presen ce o r absen ce o f va.ri ous concen trations of m eta l 
sa lts. After 48 h the cultures w ere pulsed with 1 p.Ci of 3H -TdR and 
proli fe ration was m easured with a scin tillation counte r after 16 h . Pro lifer-
ation w as expressed as coun ts per minu te (cpm ). 
Antibodies Subclasses of MH C class II restric tion determin ants of N i-
reactive T LC were characte1·ized by blocking m etal-induced TLC proEfer-
Table I. Cross- reactivity Patterns of Ni-Rc activc T L C with Other Metals" 
Donor 
2 
3 
4 
5 
6 
7 
8 
TLC 
3/4 
3/35 
3/36 
2/3 6 
MBS.44 
M DS.2 
M AB .3 
MAS.15 
M.ES.4 
MES.22 
M ES.48 
l3AJ3 .4 
BAB. 5 
PPN. 2 
PPN .l 6 
PPN .48 
PPN. 53 
PPN .5 7 
PPN.58 
PPN .84 
MHC C lass II 
R est1ic tio n' 
DR. 
DR 
DR 
D R 
DR 
DR 
D R. 
D R 
DR 
DR. 
DR 
D Q 
DR 
DR 
Oil 
DQ 
DQ 
DQ 
D R 
D il 
Co" Ni 
2.8 64.8 
3 .1 157.9 
3.3 150.9 
2.5 51.6 
0. 1 7.3 
0 .2 42.3 
0.1 23.6 
0 .1 6 .8 
1.1 17 .1 
0. 1 13.5 
1.0 16.4 
0.5 .!.§_,Q 
0 .1 32.9 
0.5 40.9 
0.2 2.0 
0.4 30. 1 
10.3 73. 1 
0.5 42.6 
0.3 ~ 
0.3 41.4 
Prolife ration (cpm x 1 o- J)b 
C u Z n Pd 
59 .2 2.3 2.4 
154.6 3.4 2.7 
203.4 3.0 3.2 
45 .4 2.1 2.8 
0. 1 0.1 10.8 
0. 1 0.1 76.5 
0 .1 0.1 iD 
0.1 0. 1 0.2 
0.9 0 .8 0.9 
0.2 0.3 0.5 
0.8 0.6 0.8 
12.4 0.2 0.2 
0 . 1 35.7 0.1 
0.4 0.4 58.6 
2.4 0.2 0.2 
~ 0.4 0.3 
62.0 0.6 ~ 
7.0 0.2 0.2 
0.4 0.2 22.5 
!QJ. 0.4 0.3 
" Crossrcactivity patterns of Ni-rcactivc TLC &om e ight d ifferen t indi vld ua.ls. TLC cclls (2-4 X 10-1 / wcl l) were cultured with auto logous APC (irradiated PBMC, 10
5/weU or 
irrad iated EB V- 13 , 2-4 X 10-1/wcll) i11 the p resence of optimal concc11tra tion s of me tal salts. After 48 h t1 1c cu ltures were pulsed w ith I IJ.Ci of 3H -Td R, and proliferation was 
measured iu counts per minu te (cpm) after .1 6 h. 
1
' Pro liferation data of Ni-rc activc T LC arc expressed ;1s the m enn cpm o f triplicate cu ltu res. St:md:u d dcvint:ions d id no t exceed 15%. U nderlined, cpm data w ith a stimulation 
index (S I) ::! 3: S l = cpm m etal- ind uced p ro li fcration /cpm proli feration wi tho u t m cral. 
c l-ILA-restrictio n was determined by blocking Ni- induccd T LC prolife ration wi th an ti-HLA-D R . anti-HLA-DQ or anti-H LA- D P monoclonal an ribodics. 
'
1 T he metals Pt, Cr. 1-lg: , and Fe d id not induce sign ifi can t pro li fc r:1tivc respo nses (d ata not shown) . 
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Table II. Inhibition of Ni- and Cu-Induced TLC 
Proliferation with Anti-HLA MoAb" 
Ni-Reactive TLC 
Presen t During C ulture'' PPN.16' PPN.48 PPN.53 
0.2 :t 0.1 0.3 :t 0.1 0.3 :t 0.1 
Ni 2.0 :t 0.1 30.1 :t 2.7 29 .8 :t 1.5 
Ni + anti-MHC class ([ Ab 0.2 :t 0. 1 0.4 :t 0.1 0.2 :t 0. 1 
Cu 2.4 :t 0.3 22.2 :t 4.4 18.4 :t 0.3 
Cu + anti-MHC class II Ab 0.2 :t 0.1 0.2 :t 0.1 0.2 ± 0.1 
"Ni-spccific TLC (2-4 X 104/wcll) were stimulated wid1 Ni (100 ILM) or C u (3 ILM) 
and autologous APC in the presence or abs~ncc of anti-HLA cl;ass II blocking moAb. 
1
' Proliferative responses arc stated as counts per minute (cpm) X 1 o-J and arc 
expressed as mea n ± SD. 
r According to their restrictions, anti-1-ILA-DR. was used for TLC PPN.l6 and 
anti-HLA-DQ was used for TLC PPN.48 and 53 . 
arion with the following antibodies: anti-HLA-DR (B.B.11 .2, ascites used at 
a dilution of 1:200, a kind gift of Dr. F. Koning, Department of lmrnuno-
hcmatology, University of Lciden, T he Netherlands), anti-HLA-DQ (SPV 
L3-8, ascites used ~t a di)ution of 1:200, a kind gift of Dr. H. Spits, T he 
Nethed apds Cancer Inst:jtute, Amsterdam, The Netherlands) and anti-
HLA-DP (B7/21, purified antibodies u~cd at 10 f.Lg/ml , a kind gift ofDr. J. 
Higgins, St. Mary's Hospital Medical School, London, UK) . 
Establishment ofEBV-B cell lines 1 o<• or 107 PBMC from patients or 
donors were cultured with 30% supernatant of the EBV-producing marmo-
set cell line B95.8 in the presence of 600-1000 ng/ml cyclosporin A 
(Sandoz, Basel, Switzerland) and were distributed at a cell concentration of 
5 X 1 04 /well in 96-well Costar flat-bottomed plates. )OBV-B were tested for 
their antigen-presenting capacitit!s before usagt! . 
RESULTS 
Cross-Reactivity to Cu and Pd T!1e T lymphocyte clones 3/36 
and MDS.2 were 'reported earlier to respon'd in terms of prolifera-
tion, a11d IL-2 and ipterferon-y productio!'l upon recognition ofNi 
(7 ,8). Cross-reactivity of these TLC was subsequently investigated 
by detennining proliferative responses to various con centrations of 
Ni and other metals in the presence of MHC-m atched EBV-B or 
autologous PBMC as antigen-presenting cells (APC) . TLC 3/36 
and MDS.2 exclusively cross-reacted to C u and Pd, respectively 
(Fig 1). The maximal stimulatory concentration for C u was tenfold 
lower than the concentration of Ni needed for ma x imal TLC 
proliferation. Pd induced a considerably high er prolife rative re-
sponse in TLC MDS.2 as compared to Ni. A ro le of Ni-contami-
nation in Cu- and Pd-induced proliferations cou ld be excluded on 
the basis of the purity of the metal-saJts used in this study. 
Cross-reactivity patterns w ere further investigated in these and 18 
other Ni-reactive TLC obtained from eight different individuals in 
total. This analysis revealed three major types of cross-reactivity 
patterns: i) cross-reactivity with C~1, ii) cross~reactivi ty with Pd, and 
iii) no cross-re'!ctivity with other metals (Table I) . Cross- reactiv-
ities were independent from the usc of EBV-B or autologous 
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PBMC as APC. lncidental cross-reactivities with Zn and Co w ere 
observed only at the highest concentrations tested (300 J.tM) in 
TLC BAB.S and PPN. 53, respectively (Table 1). 
Cross-reactivity Is MHC Class II Restricted Optimal stimu-
latory concentrations of Cu and Pd clearly did not stimu late all 
Ni.-reactive TLC (Table I) or housedust mite peptide- specific TLC 
(data not shown) , indicating that, like Ni, these metals are not 
mitogenic (9). To further stud y mechanisms underlyin g cross-
reactivity, MHC restrictions of Ni-reactive TLC responding to 
cross-reactive metal s were de termined . By blocking experiments 
with anti- HLA-DR, -DQ, or -DP antibodies, we first established 
that on ly HLA-DR and -DQ restrictions played a ro le in Ni-
recognition by the present TLC panel (see Table 1). Using three 
Ni-reactivc TLC of the PPN-series (see Table I, donor 8) we 
o bserved that Cu-induced proliferative responses were blocked also 
by the respective anti-MHC class II antibodies (Table II). The 
suggestion that cross-reactive meta ls and Ni use the sam e restriction 
elements was further confirmed by investigatin g the ab ili ty of 
Ni-reactive TLC PPN.16 ;md PPN.48 to respond toNi and Cu and 
Ni-reactive TLC MDS.2 <Jnd MBS.44 to respond to Ni am! Pd in 
the presence of autologous, HLA-matchcd or HLA-mismatched 
A PC. TLC PPN .16 (DR.-restricted) only recognized Ni and C u in 
the presence of HLA- PR1-typed APC, whereas PPN.48 (DQ-
restri cted) only recognized Ni and C u in the presen ce of HLA-
DQw1-typed APC, (Table III) . Ni- and Pd-induced proliferative 
responses of th e 1\t).DS.2 (DR.-restricted) and MBS.44 (DR.-re-
stricted) TLC were only detected in the presence of HLA-DR4-
and HLA-DRw11-typed APC respectively (Table IV). 
DISCUSSION 
Using a large panel ofNi-re<Jctive TLC derived from e ight different 
Ni-allergic donors, possible cross-reactivities of these TLC with 
oth er metals w ere investigated. T he results o btained show that 
m ost (15 of 20) of these clones are un able to distinguish Ni from 
either Cu o r Pd. No differences between MHC class I! rcstdction 
pattems for Ni- and C u- , or Pd-induced proliferative responses 
were found . Cross-reactivities with C u o r Pd were observed in both 
DR- and DQ-restricted Ni-reactive TLC. 
Haptens can alter non-antigenic autologous proteins in to anti-
genic structures by binding to amino acid residues [2,1 0]. R ecent 
investigations have shown that Ni can bind to peptides p1·esent in 
tl1e g rooves ofMHC class II m o lecules, through its interaction w itl1 
the amino ac id res idue histidin [3,11,12) . Ni-modified peptide-
C lass If complexes are then recognized by N i-reactive T cells. 
Because biva lent C u-ions are also able to bind to h.i stidin [13) , 
cross-reactivity of Ni-reactive TLC with this m etal is most like ly to 
h e explained b y molecular mimicry. Apparently, within sets of 
Ni-reactive T cells some of these are unable to discriminate 
between Ni- or C u-modified peptide-MHC class II complexes. 
Although the preferential binding site of Pd is not known, the same 
reasoning may bold true for this metal. The fact that both metals arc 
Table Ill. HLA Restriction of Ni- and Cu-Induced TLC Proliferation" 
DR 
1,3' 
1,3 
1,2 
3,4 
4,w9 
7,w8 
APC 
Haplotype 
DQ 
wl,w2 
wl,w2 
w1 
w2,w3 
w3 
w2 
0.2 :t 0.1 
0.1 :t 0.0 
0.1 :t 0.0 
0. 1 :t O.l 
0.1 :t 0.0 
0.1 ± 0.1 
PPN.l6 (DR Restricted) 
Ni 
3.0 :t 0.7 
14.4 :t 0.3 
3.4 ± 0.6 
0.7 :t 0.1 
0.1 :t 0.1 
0.1 ± 0.0 
TLC Proliferation (cpm X 1 o- ' )1' 
PPN.48 (DQ Restricted) 
C u Ni Cu 
1.4 :t 0.1 0.2 :t 0.1 29.5 :t 1.9 11.4 :t 3.0 
7.5 :t 0.5 0.2 :t 0.'1 42.6 :!:: 0.1 31.1 ± 3.6 
2.0 ± 0.1 0.1 :t 0.1 8.6 :t 1.9 1.7 ± 0.2 
0.4 :t 0.1 0.1 :t o..o 1.4 :t 0.4 0.6 :t 0.2 
0.2 :t 0.1 0.2 :t 0.0 0.2 :t 0.0 0.3 :t 0.0 
0.1 :t 0.0 0.2 ± 0.0 0.2 :t 0.0 0.3 ± 0.0 
" Ni-spccifi c TLC (2-4 X 104 / wcll) were stimulated with Ni (100 ILM) or C u (3 ILM) in the presence of APC (irradiated PDMC , '105/ wcU) from six donors with diffe rent HLA 
class II haplorypcs. 
"Counts per minute (cpm) expressed as mean ::!:: SD. 
' Aumlogous APC. 
VOl. 105, NO . I JULY 1995 C R OSS-REACTIVIT Y OF N I-SPECIFIC T-CELL CLO N ES 95 
Table IV. HLA Restriction of Ni- and Pd-Induced TLC Proliferation" 
APC 
Haplotype MDS. 2 (DR R.cstrictcd) 
DR DQ Ni 
4,w6r w1,w3 0.2 ::':: 0.0 18.1 ::':: 0.5 
4,7 w2 o. ·1 .::+:: 0.1 12.7 ::':: 1.1 
3,4 w2 0. 2 ::':: 0.1 6 .8 ::':: 0 .7 
2,w6 w ·l 0.1 ::':: 0 .0 0.2::!: 0.1 
4,w11" wl NO ND 
l ,w ·lt wl,w3 0.2 .::+:: 0.1 0.3 ::!: 0. 1 
1,3 w1,w2 0. 1 ::':: 0.0 0.8::!: 0.1 
"Ni-spccitic TLC (2-4 X I O'/wc ll) were stimulated w ith Ni or Pd (HlO J.LM) in the 
pre sen ce of APC (irr"diiltcd PDM C, \ 05 / wcll) fro m seven douors with diffc rcm HLA 
class II haplotypes. 
b Counts per minute (cpm) expressed as m cnn ± SO. 
directly neighboring Ni within the periodic table of the elements 
may further contribute to the high frequency with which these 
cross-reactivities are observed for Ni-reactive TLC. However, 
physico-che mical differences, e.g., in ion-radius do exist between 
these m etals , apd these differences may explain why T -cell recep-
tors sharing affin ities for both Ni and Cu onl y ver-y in ti-eque ncl y 
show additional recognition ofPd. In the present panel ofTLC o nly 
one Ni-reactive TLC (PPN .53 ) was found showin g multiple cross-
reactivities, including not only Cu but also Pd . Nptably, this clone 
was also the only one showing cross-reactivity with Co, but the 
significance of the latter proliferative response is unclear because it 
was only observed at a ver-y high dose. 
T he present results may have clinical relevan ce . The three metals 
located next to Ni in the peri odic table of elements (Co, Cu, and 
Pd) are all known to be contact sensitizers. Patch tes t studies in 
Ni- allergic patients revealed that some of these patients are simul-
taneously hypersensitive to Co, Cu, or Pd, ;md that ACD to Co, 
Cu, or Pd is usually combined with a sensitivity toNi [14 ,15-18] . 
Although for the patients used he re only Ni and Co patch-test data 
were available, o ur present results indicate that at least part of these 
multiple i11 11 i11o reactivities can be explained by cross-reactivity of 
Ni-rea ctive TLC with C u or Pd. C linically these simultaneous 
hypersensi6vities are, however, rather rare as compared to the 
frequency of clonal cross-reactivities observed here: 10 of 20 
Ni-reac tive TLC cross-reacted with Cu and 6 of 20 with P~. 
Possibly other fitc tors determinin g the development of allergic skin 
hypersensi.tiviti es account for this discrepancy, such as a lower risk 
of exposure to bivalent C u an~ Pd, and / or lower epidermal 
pen etration of these allergens. Moreover, concerning C u, body 
fluids contain high concentrations of C u-bindin g proteins like 
ceruloplasmin, possibly preventing C u from associaLion with APC. 
Our finding that Ni-specific TLC on ly infrequently (l of 20 
clones) cross-react with Co would confi rm the widely held view 
that i11 ui11o Ni and Co hypersensitivities rep resent truly distinct 
allergies [15 ,16]. However, exceptions to this rule may occur 
because the Co/Ni cross- reactive TLC PPN .53 was obtained from 
donor 8 who, in contrast to other donors, had a positive skin test for 
Co (data not shown) . T herefore, simultaneous skin hypersensitiv-
ities toNi and Co may still incidenta lly be based o n cross-reactivity 
at the T -cell clonal le vel. T hat ACD to the allergen C r occurs 
independent from Ni-all ergy is also well-known. In concordance 
with this fa ct, none of the Ni-reactive T -ce l.l clones showed 
proliferative responses to this metal [1 9,20]. Similarly, for Fe, Zn, 
and Pt, which arc not known as contaq allergens, no cross-
reactivities with Ni-reactive T.LC were observed , except for o ne 
clone showing reactivi ty to Z n at a very hig \1 dose. 
ln conclusio n , in a large panel ofNi-reactive T-ccll clones, most 
clones showed ;, !Jitro cross-reactivity to either C u o r Pd. Both 
metals are neighboring Ni in the periodic table of elements. T he 
present data indicate that concomitant hypersensitivities of Ni-
allergic patients to C u or Pd ;, l' i"o can be due to cross-reactivities 
TLC Proliferation (cprn X 1 0- 3) 1' 
Pd 
31.4 ::':: 3.0 0.1 ::':: 0.0 
14.4 .::':: 0.8 0.2 ::':: 0.0 
11.2 ::':: 1.7 0.3 ::':: 0. :1 
0.1 ::!: 0.0 ND'" 
ND 0.1 ::!: 0.0 
0. 1 ::':: 0.0 0.2 ::':: 0.1 
0.4 ::!: 0.1 0.3 ::!: O.J 
' Aurologous APC for T LC MDS.2. 
"Autologous APC fo r TLC Ml3S.44. 
,. Np, not done. 
MBS.44 (DR Restricted) 
Ni Pd 
0.2 ::':: 0.2 0.8 ::':: 0.1 
1.1 .::+:: 0.1 0.1 .::+:: 0.0 
0.1 ::':: 0.0 0.4 ::':: 0 .1 
ND ND 
3 1.2::!: 4.1 18.7 ::!: 0.7 
7.6 ::!: 0.9 13.6 ::':: 0.9 
0.1 ::!: 0.0 0.4 ::!: 0.1 
at the T - cell clonal level. T he lack of ill llifro TLC responsiveness to 
Co supports the view that Ni and Co allergies are distinct entities . 
T his work utas supported by Bioredmology R esearch lmtclf'atitle Det1e/opmeut 'if 
Growi/1 Europe (BRIDGE) graut BIOT-CT 18036 (FHMP). 
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